Fuse Medical Stock Fundamentals
| FZMD Stock | USD 0.12 0.07 140.00% |
Fuse Medical fundamentals help investors to digest information that contributes to Fuse Medical's financial success or failures. It also enables traders to predict the movement of Fuse Pink Sheet. The fundamental analysis module provides a way to measure Fuse Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fuse Medical pink sheet.
Fuse |
Fuse Medical Company Operating Margin Analysis
Fuse Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Fuse Medical Operating Margin | (0.05) % |
Most of Fuse Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fuse Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Fuse Medical has an Operating Margin of -0.0497%. This is 99.86% lower than that of the Health Care Providers & Services sector and 99.87% lower than that of the Health Care industry. The operating margin for all United States stocks is 99.1% lower than that of the firm.
Fuse Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fuse Medical's current stock value. Our valuation model uses many indicators to compare Fuse Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fuse Medical competition to find correlations between indicators driving Fuse Medical's intrinsic value. More Info.Fuse Medical is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fuse Medical's earnings, one of the primary drivers of an investment's value.Fuse Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fuse Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fuse Medical could also be used in its relative valuation, which is a method of valuing Fuse Medical by comparing valuation metrics of similar companies.Fuse Medical is currently under evaluation in operating margin category among its peers.
Fuse Fundamentals
| Return On Asset | -0.0331 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | (0.05) % | |||
| Current Valuation | 12.09 M | |||
| Shares Outstanding | 72.9 M | |||
| Shares Owned By Insiders | 88.44 % | |||
| Price To Sales | 0.57 X | |||
| Revenue | 20.41 M | |||
| Gross Profit | 11.94 M | |||
| EBITDA | (1.42 M) | |||
| Net Income | (1.59 M) | |||
| Cash And Equivalents | 604 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 200 K | |||
| Debt To Equity | 106.80 % | |||
| Current Ratio | 1.15 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (1.78 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.71 | |||
| Market Capitalization | 9.84 M | |||
| Total Asset | 18.3 M | |||
| Retained Earnings | (2.8 M) | |||
| Working Capital | 2.31 M | |||
| Current Asset | 2.31 M | |||
| Current Liabilities | 2.14 K | |||
| Z Score | 30.4 | |||
| Net Asset | 18.3 M |
About Fuse Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fuse Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fuse Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fuse Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Fuse Pink Sheet
Fuse Medical financial ratios help investors to determine whether Fuse Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fuse with respect to the benefits of owning Fuse Medical security.